A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2-positive breast cancer.
If you want an argument in favor of teaching the humanities, I suggest you ask a medical educator. Across the U.S., the age-old debate about
Digital breast tomosynthesis (DBT) increased breast cancer detection rates and showed invasive cancers with a lower rate of advanced cancers compared with digital mammography, according